Biomerica, Inc. (BMRA)

NASDAQ: BMRA · Delayed Price · USD
3.96
0.01 (0.25%)
At close: Jan 27, 2022 4:00 PM
4.00
0.04 (1.01%)
After-hours:Jan 27, 2022 5:53 PM EST
Market Cap50.89M
Revenue (ttm)10.59M
Net Income (ttm)-6.98M
Shares Out12.85M
EPS (ttm)-0.45
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume157,563
Open4.14
Previous Close3.95
Day's Range3.77 - 4.30
52-Week Range3.30 - 8.15
Beta-0.69
AnalystsBuy
Price Target13.00 (+228.3%)
Earnings Daten/a

About BMRA

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely ...

IndustryHealth Care Equipment & Supplies
Founded1971
Employees66
Stock ExchangeNASDAQ
Ticker SymbolBMRA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for Biomerica stock is "Buy" and the 12-month stock price forecast is 13.00.

Price Target
$13.00
(228.28% upside)
Analyst Consensus: Buy

News

Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

IRVINE, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its second quarter fiscal 2022 financial ...

2 weeks ago - GlobeNewsWire

Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced certain preliminary financial results for the second fiscal quarter ended November 30, 20...

1 month ago - GlobeNewsWire

Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening

IRVINE, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that Dr. Brooks Cash, one the nation's most recognized leaders in Gastroenterology medicine, has agreed to...

2 months ago - GlobeNewsWire

Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS)...

IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Canadian Patent Office has issued a notice of allowance for Biomerica's patent application perta...

2 months ago - GlobeNewsWire

Biomerica Launches New Website for Its Aware® Breast Exam Device

IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness month, which takes place each October, ...

2 months ago - GlobeNewsWire

Recap: Biomerica Q1 Earnings

Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announcement.

3 months ago - Benzinga

Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test

IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ colorectal ...

3 months ago - GlobeNewsWire

Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021

IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 financial r...

3 months ago - GlobeNewsWire

Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to Pop

According to Fintel, here are five short squeeze stocks that are among the most likely to see a squeeze attempt moving forward. The post Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think...

Other symbols:ATERPROG
3 months ago - InvestorPlace

5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted s...

Other symbols:ATERMRINPROG
3 months ago - Benzinga

BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today

Biomerica (BMRA) stock is surging higher on Friday thanks to a new deal with Walmart (WMT) concerning its EZ Detect product. The post BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smilin...

Other symbols:WMT
3 months ago - InvestorPlace

Biomerica's Shares Gain As Its Colon Disease Screening Test Goes For Sale At Walmart Online

Biomerica Inc (NASDAQ:BMRA) has entered into a Supplier Agreement with Walmart Inc (NYSE:WMT) to sell its EZ Detect colorectal disease screening test within the Walmart retail system.  Beginning this we...

3 months ago - Benzinga

Walmart Now Selling Biomerica's EZ Detect™ Colorectal Screening Test

IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that it has entered into a General Merchandise Supplier Agreement with Walmart for the sa...

3 months ago - GlobeNewsWire

Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrom...

IRVINE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods® diagnostic-guided ther...

4 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2021 Year End Results

IRVINE, Calif., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2021 financial results. During...

5 months ago - GlobeNewsWire

Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression

IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica's first patent pertaining t...

5 months ago - GlobeNewsWire

Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test

IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced the launch of their new website for their EZ Detect™ Colon Disease Test product at https://ezdetect.com. T...

5 months ago - GlobeNewsWire

Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori...

IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribut...

7 months ago - GlobeNewsWire

Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testi...

IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Mexican Patent Office has issued a notice of allowance for Biomerica's patent application pertai...

7 months ago - GlobeNewsWire

Biomerica to Participate in Upcoming Investor Conferences

IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor c...

7 months ago - GlobeNewsWire

Biomerica's Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab

IRVINE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, announced that its new COVID-19 Antigen Rapid Test can now be performed w...

8 months ago - GlobeNewsWire

Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020

IRVINE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced its fiscal third quarter 2021 financial results for the...

9 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

IRVINE, Calif., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced financial results for its second quarter of fiscal year ...

1 year ago - GlobeNewsWire

Biomerica News: 10 Things for Potential BMRA Stock Investors to Know Today

Biomerica (BMRA) news for Tuesday concerning its rapid test for the novel coronavirus coming to new countries has BMRA stock on the rise. The post Biomerica News: 10 Things for Potential BMRA Stock Inve...

1 year ago - InvestorPlace

Biomerica's Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it has received CE Mark for its new COVID-19 Rapid Antig...

1 year ago - GlobeNewsWire